Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Steven Cohen (NPI 1366775405)

Field	Value
Entity Type	Individual
Organization	Steven Cohen
Address	8600 Quivira Rd Ste 100
City	Lenexa
State	KS
ZIP	66215
Taxonomy	Ophthalmology Physician
NPI Enumerated	September 8, 2009

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

This provider’s Medicare activity is overwhelmingly driven by intravitreal biologic injections: J0178 (aflibercept) accounts for $1.5M and 62.1% of Medicare revenue, J2777 (faricimab) contributes $412.4K (17.4%), and J2778 (ranibizumab) adds $137.2K (5.8%); the precomputed top-3 share is 85.2% of this provider’s total Medicare revenue, indicating a clinic model focused on recurring retina injections. The code mix and dollar concentration point to a service line built around anti-VEGF/anti‑VEGF‑adjacent drug delivery rather than general ophthalmology or high-volume surgery.

Revenue concentration is high: the three drug codes alone make up 85.2% of Medicare revenue, while total Medicare revenue is $2.4M and there is no Medicaid billing on file. This effectively makes the provider a single‑payer (Medicare) operation in public programs, exposing overall revenue to utilization and pricing shifts in these few high-value biologic codes.

Competitive standing on the top drug code is moderate rather than dominant: J0178 ranks #468 of 3204 (85th percentile; typical, unremarkable volume for this code), J2777 ranks #743 of 2039 (63th percentile; typical, unremarkable volume for this code), and J2778 ranks #540 of 1208 (55th percentile; typical, unremarkable volume for this code). In short, the provider bills large absolute dollars for J0178 but sits within expected national utilization patterns rather than as an extreme outlier.

Diagnostic and office-service volume is elevated relative to peers: 92134 (retinal imaging) shows 2.1K claims and $56.8K revenue and ranks #947 of 26868 providers (96th percentile; notably above typical national volume), and 92014 (comprehensive established exam) has 864 claims and $71.7K revenue and ranks #2238 of 35415 providers (94th percentile; notably above typical national volume). These high percentiles suggest strong throughput of imaging and follow-up visits that support ongoing injection therapy.

Surgical and procedural volumes are small compared with injection activity: vitrectomy 67042 (20 claims, $16.6K) and retinal detachment repair 67108 (14 claims, $12.3K) together represent a minor share of Medicare revenue. The pattern—high injection and imaging counts with low surgical counts—is consistent with an outpatient retina/injection clinic rather than a surgery‑heavy retina subspecialty practice.

Payer mix is effectively single‑payer public: the provider reports $2.4M in total Medicare revenue and no Medicaid billing on file (none below). Analysts should treat this entity as Medicare‑dependent for public program volume and reimbursement exposure, with no Medicaid contribution reported to diversify public-payer risk.

Tenure in public programs is longstanding: the NPI was enumerated on 2009-09-08 (~17 years ago), indicating over a decade of Medicare participation that supports the observed build‑out of an injection-focused outpatient workflow. Long enrollment combined with concentrated drug billing suggests an established practice pattern rather than a new or transient billing profile.

Several codes show contrasting statistical signals: while the big revenue driver J0178 produces large absolute revenue, its descriptor is "typical, unremarkable volume for this code," whereas ancillary services 92014 and 92134 are both described as "notably above typical national volume." This mix indicates average national positioning for high-cost drug administration but above‑typical intensity in diagnostic follow-up and monitoring that likely sustains repeat injections.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,150	$690	$1.5M
J2777	Injection, faricimab‑svoa, 0.1 mg	14,220	$30	$412.4K
J2778	Injection, ranibizumab, 0.1 mg	760	$180	$137.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,310	$90	$118.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	860	$80	$71.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,100	$30	$56.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	150	$160	$24.5K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$830	$16.6K
67108	The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or…	10	$880	$12.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$110	$11.8K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Steven Cohen — 2 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	30	1,770	$690	$1.3M
J2777	10	30	12,060	$30	$575.7K
J2778	14	20	860	$180	$297.6K
67028	16	40	1,170	$90	$111.4K
J7312	10	10	260	$160	$43.6K
67042	12	20	20	$1,140	$31.9K
67108	14	20	20	$1,130	$24.8K
J3590	16	20	200	$100	$24.1K
92014	19	530	180	$70	$18.5K
99214	2,400	4,310	120	$70	$16.4K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Steven Cohen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Steven Cohen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bethesda Lutheran Communities	KS	Mental Illness Intermediate Care Facility	$0	$17.6M
Cherub Medical Supply, LLC	KS	Durable Medical Equipment & Medical Supplies	$0	$6.3M
Mawd Pathology Group Inc	KS	Anatomic Pathology & Clinical Pathology Physician	$660	$5.9M
Gregory Fox	KS	Ophthalmology Physician	$4M	$0
Ravi Singh	KS	Ophthalmology Physician	$3.9M	$0
Cpf Senior Living - Lenexa LLC	KS	Assisted Living Facility	$0	$3.8M
Beatty Suiter	KS	Ophthalmology Physician	$3.5M	$0
Ryan Christensen	KS	Ophthalmology Physician	$3.3M	$0
180 Medical, Inc.	KS	Durable Medical Equipment & Medical Supplies	$0	$2.7M
Midwest Division-oprmc LLC	KS	General Acute Care Hospital	$0	$2.6M

Steven Cohen — Billing Profile & Reimbursement Data

Sign up for Steven Cohen — Billing Profile & Reimbursement Data policy alerts

Steven Cohen — Billing Profile & Reimbursement Data

Sign up for Steven Cohen — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References